Sort
82,697 grants matching “vaccine development”
Designing and optimizing candidate HIV vaccines and boosting protocols
$962,348David Nemazee · Scripps Research Institute, The · R01 · FY2021 · AI
Designing and optimizing candidate HIV vaccines and boosting protocols
$962,348David Nemazee · Scripps Research Institute, The · R01 · FY2020 · AI
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$962,333Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2023 · GM
Role of Innate Immune Dysregulation in the Etiology of Dementia
$962,256Annelise Emily Barron · Stanford University · DP1 · FY2022 · AG
High-throughput immunoproteomics for cancer biomarker discovery
$962,182Joshua Labaer · Arizona State University-Tempe Campus · U2C · FY2023 · CA
Impact of HIV on the human alveolar environment drivingthe early events of Mycobacterium tuberculosis infection
$962,145Jordi B Torrelles · Texas Biomedical Research Institute · R01 · FY2025 · AI
Novel Targets for Vaccine Therapy
$962,130Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Cryopreservation of Anopheles Embryos
$962,110Peter F. Billingsley · Sanaria, Inc. · R44 · FY2021 · AI
Development
$962,061Ana M Navarro · University Of California, San Diego · U54 · FY2011 · CA
Characterization of immunogenic and structural properties of HIV-1 envelope
$962,051Michael W Cho · Iowa State University · P01 · FY2010 · AI
Louisiana Clinical and Translational Science Center
$961,973John P. Kirwan · Lsu Pennington Biomedical Research Ctr · U54 · FY2021 · GM
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$961,866Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Enhancing DNA vaccines using modified Bacterial Toxin A1 Subunits as adjuvants
$961,830Timothy R Fouts · Profectus Biosciences, Inc. · R44 · FY2011 · AI
N-glycan baiting to target the highly effective HIV Env shield
$961,798Richard Thomas Wyatt · Scripps Research Institute, The · R01 · FY2021 · AI
N-glycan baiting to target the highly effective HIV Env shield
$961,798Richard Thomas Wyatt · Scripps Research Institute, The · R01 · FY2023 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza
$961,771Daniel Hoft · Saint Louis University · N01 · FY2019 · AI
4-(Aminomethyl) benzamides as novel anti-Ebola agents
$961,660Lijun Rong · Chicago Biosolutions, Inc. · R42 · FY2020 · AI
Ebola Virus Disease Animal Model Refinement
$961,399National Institute Of Allergy And Infectious Diseases · Y01 · FY2017 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites
$961,340Sumana Chakravarty · Sanaria, Inc. · R44 · FY2022 · AI
HIV VACCINE CLINICAL TRIALS UNIT
$961,319Michael C Keefer · University Of Rochester · U01 · FY2006 · AI
REPTOR: accelerating antibody discovery and improving hits with machine learning
$961,244Natalie Castellana · Abterra Biosciences, Inc. · R44 · FY2025 · GM
Macaque Core -Core B
$960,730Vijayakumar Velu · Emory University · U19 · FY2016 · AI
BIOLOGY OF ALIMENTARY EPITHELIA IN HEALTH AND DISEASE
$960,665Children'S Hospital Boston · P30 · FY2000 · DK
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$960,557Galit Alter · Massachusetts General Hospital · R01 · FY2021 · AI
Systems Biology Approaches to Viral Pathogenesis and Immunity
$960,510Michael G Katze · Oregon Health & Science University · U54 · FY2011 · AI